43 天前 - … Western medicine therapy also provide new ideas and means for the immunotherapy
of triple negative breast cancer (TNBC). With the development of immunotherapy research…

43 天前 - … promising targets in triple negative breast cancer. Pharmacol … in early-stage triple
negative breast cancer (TNBC). … [Pembrolizumab plus chemotherapy combination - first line in …

46 天前 - … In conclusion, biomaterial-mediated PTT combined with vessel normalization is
a promising strategy for effective immunotherapy of triple-negative breast cancer (TNBC). …

46 天前 - … treatment option for TNBC is chemotherapy using anthracyclines or carboplatin
rather than immunotherapy as its triple-negative … challenging breast cancer subgroup to treat, …

46 天前 - … (ICIs), has revolutionized the treatment of all cancers. In breast cancer, the most
robust data for ICIs exist in the space of triple-negative breast cancer (TNBC), where the …

47 天前 - … treatments in detail, ranging from chemotherapy (especially anthracyclines), surgery,
anesthetics, radiotherapy to immunotherapy… intelligence and traditional Chinese medicine. …

47 天前 - … Tumor-associated macrophages (TAMs) and other myelomonocytic cells are implicated
in regulating responsiveness to immunotherapies… of triple-negative breast cancer (TNBC…

47 天前 - … combining immunotherapy with radiotherapy, GM-CSF, and thymosin alpha-1 in
treating a breast cancer patient who did not respond to multiple lines of advanced therapy. Our …

49 天前 - … curves for targeted therapy. - Figure 3: ROC and precision-recall curves for
immunotherapy. - … p-values for BC-SELECT and its two components in the context of …

50 天前 - … in triple negative breast cancer (TNBC) or the FGFR1/SRC/STAT3 pathway in ovarian
cancer promotes tumor … with consequences for tumor immunotherapy. The tolerance and …